XOMA Corporation (XOMA) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
21 May, 2026Opening remarks and agenda
Chairman introduced the board of directors, executive team, and external advisors present at the meeting.
Outlined the meeting agenda, including business items, voting procedures, and Q&A session.
Board and executive committee updates
Listed the directors standing for election to serve until the 2027 annual meeting.
Shareholder proposals
Considered election of directors, ratification of Deloitte & Touche as auditor, amendment and restatement of the 2010 Long Term Incentive and Stock Award Plan, approval of the 2026 Employee Stock Purchase Plan, and advisory approval of executive compensation.
Partial view of Summaries dataset, powered by Quartr API
Latest events from XOMA Corporation
- Merger proposal offers $39/share plus a litigation-tied CVR; board and major holders support approval.XOMA
Proxy filing10 Jun 2026 - Amendment adds HoldCo to the merger, clarifies terms, and outlines key risks and approvals needed.XOMA
Proxy filing18 May 2026 - FY2025 receipts topped $50M; Q1 2026 net income $4.5M; Ligand merger and portfolio growth drive outlook.XOMA
Q1 202612 May 2026 - Acquisition of XOMA Royalty adds significant royalty assets, accelerates growth, and avoids dilution.XOMA
Proxy filing28 Apr 2026 - Ligand to acquire XOMA Royalty for $39/share plus CVR, expanding its royalty portfolio and growth.XOMA
Proxy filing27 Apr 2026 - Virtual annual meeting to vote on directors, auditor, incentive plans, and executive pay.XOMA
Proxy filing30 Mar 2026 - Shareholders will vote on director elections, auditor ratification, equity plans, and executive pay.XOMA
Proxy filing30 Mar 2026 - Royalty receipts rose 68% and the portfolio doubled, fueling strong cash flow and profitability.XOMA
Q4 202518 Mar 2026 - Diversified royalty portfolio, strong cash flow, and major pipeline catalysts ahead.XOMA
Leerink Global Healthcare Conference 202611 Mar 2026